Beone Medicines Ltd. Class A · SSE:688235
Beone Medicines Ltd. Class A shareholders
As of Jun 30, 2026, 274 institutions reported holding Beone Medicines Ltd. Class A. Largest: Baker Bros. Advisors LP, Capital Group and Primecap Management Co. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Beone Medicines Ltd. Class A | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 8.8M | +2,514 | Aug 14, 2026 | |
| Capital Group | 6.75M | +675K | Aug 12, 2026 | |
| Primecap Management Co | 5.01M | +32,750 | Aug 14, 2026 | |
| Fidelity | 2.48M | −1.22M | Aug 13, 2026 | |
| Citadel | 1.43M | +393K | Aug 14, 2026 | |
| Temasek Holdings (Private) Ltd | 846K | −16,914 | Aug 7, 2026 | |
| T. Rowe Price | 759K | +219K | Aug 14, 2026 | |
| BlackRock | 695K | +37,117 | Aug 7, 2026 | |
| Millennium | 543K | +338K | Aug 14, 2026 | |
| Morgan Stanley | 497K | +32,965 | Aug 13, 2026 |